NovaBay Pharmaceuticals, Inc. Operating Income Growth

Operating Income Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending September 30, 2022 was 80.03% (a -607.8% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth decreased by -197.98%
  • Annual Operating Income Growth for 2021 was -37.91% (a -219.82% decrease from previous year)
  • Annual Operating Income Growth for 2020 was 31.64% (a -262.84% decrease from previous year)
  • Annual Operating Income Growth for 2019 was -19.43% (a 153.66% increase from previous year)
  • Twelve month Operating Income Growth ending September 30, 2022 was -10.22% (a -73.89% decrease compared to previous quarter)
  • Twelve month trailing Operating Income Growth decreased by -73.04% year-over-year
Trailing Operating Income Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-10.22% -39.14% -51.68% -37.91%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of NovaBay Pharmaceuticals, Inc.

Most recent Operating Income Growthof NBY including historical data for past 10 years.

Interactive Chart of Operating Income Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 80.03% -15.76% -56.71%
2021 -81.68% -11.01% -73.58% 0.98% -37.91%
2020 21.45% -20.44% 22.34% 62.29% 31.64%
2019 -38.92% 5.36% 33.8% -71.92% -19.43%
2018 -510.97% 16.6% -18.55% 37.3% -7.66%
2017 119.31% -5.24% 21.56% 18.79% 33.43%
2016 67.62% 61.46% 53.9% 0.21% 48.04%
2015 -27.76% -30.03% -28.34% -13.74% -25.04%
2014 -0.82% -37.93% 8.77% -17.52% -9.16%
2013 -71.19% -2713.21% -44.35% -40.32% -86.38%
2012 -15.19% 69.54% -753.41% -27.76% -92.29%
2011 -4013.33% 4.32%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology